Editorial
Setting the base for new therapeutic strategies against thymic epithelial tumors—miR-145-5p epigenetic regulation
Abstract
The rarity and biological variety of thymic malignancies hampers the performance of randomized clinical trials and thus limits the availability for guidelines in treatment decisions.
